Company Filing History:
Years Active: 2025
Title: Amelie Burk-Körner: Innovator in Colorectal Cancer Biomarkers
Introduction
Amelie Burk-Körner is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer research, particularly in identifying biomarkers for colorectal cancer. Her innovative work has the potential to enhance early detection and treatment strategies for this prevalent disease.
Latest Patents
Amelie holds a patent for the "Use of BMMFI Rep protein as a biomarker for colorectal cancer." This invention relates to the application of the BMW Rep-protein as a biomarker, which could play a crucial role in the diagnosis and monitoring of colon cancer. Her research emphasizes the importance of early detection in improving patient outcomes.
Career Highlights
Amelie is affiliated with the Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts, where she conducts her research. Her work is characterized by a commitment to advancing cancer diagnostics and treatment methodologies. With a patent portfolio that includes 1 patent, she is recognized for her innovative contributions to medical science.
Collaborations
Throughout her career, Amelie has collaborated with esteemed colleagues, including Timo Bund and Harald Zur Hausen. These partnerships have fostered a collaborative environment that enhances the impact of her research on colorectal cancer.
Conclusion
Amelie Burk-Körner's work in identifying biomarkers for colorectal cancer represents a significant advancement in medical research. Her dedication to improving cancer diagnostics is commendable and highlights the importance of innovation in healthcare.